People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Pharmaceuticals, Other Health Care, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Catalent, Inc. | — | Pharmaceuticals | Growth/Late | $650.0M | $23.6B | 2019 |
| Invuity, Inc. | — | Other Health Care | Series B | $105.7M | $507.3M | 2015 |
| Synthetic Genomics Inc | — | Other Energy | Series B | $55.0M | $116.0M | 2010 |
| Ortho Kinematics, Inc. | — | Other Health Care | Series B | $49.9M | $9.1M | 2018 |
Gregory T. Lucier at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gregory T. Lucier on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Jurvetson | 1 | 10 |
| Barry Schuler | 1 | 9 |
| Dana Mead | 1 | 7 |
| Dana G. Mead, Jr. | 1 | 7 |
| Juan Enriquez | 1 | 6 |
| Chris Ehrlich | 1 | 6 |
| Eric W. Roberts | 1 | 4 |
| Gregory B. Brown | 1 | 4 |
| Evan Melrose | 1 | 4 |
| Kenneth Hayes | 1 | 3 |
| Jonathan Diamond | 1 | 2 |
| Joseph Pepper | 1 | 2 |
| Gary Curtis | 1 | 2 |
| Jon Diamond | 1 | 2 |
| Greg Lucier | 1 | 2 |
| Kenneth Trauner | 1 | 2 |
| Adam Deitz | 1 | 2 |
| Gary L. Stevenson | 1 | 2 |
| Gigi Brisson | 1 | 2 |
| Jim Flatt | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.